Coagulation cascade and complement system in systemic lupus erythematosus

This study was conducted to (1) characterize coagulation cascade and complement system in systemic lupus erythematosus (SLE); (2) evaluate the associations between coagulation cascade, complement system, inflammatory response and SLE disease severity; (3) test the diagnostic value of a combination of D-dimer and C4 for lupus activity. Transcriptomics, proteomics and metabolomics were performed in 24 SLE patients and 24 healthy controls. The levels of ten coagulations, seven complements and three cytokines were measured in 112 SLE patients. Clinical data were collected from 2025 SLE patients. The analysis of multi-omics data revealed the common links for the components of coagulation cascade and complement system. The results of ELISA showed coagulation cascade and complement system had an interaction effect on SLE disease severity, this effect was pronounced among patients with excess inflammation. The analysis of clinical data revealed a combination of D-dimer and C4 provided good diagnostic performance for lupus activity. This study suggested that coagulation cascade and complement system become ‘partners in crime’, contributing to SLE disease severity and identified the diagnostic value of D-dimer combined with C4for lupus activity.

[1]  C. Mohan,et al.  Lupus nephritis biomarkers. , 2017, Clinical immunology.

[2]  M. Kretzler,et al.  A systems approach to renal inflammation in SLE. , 2017, Clinical immunology.

[3]  C. Grunau,et al.  Integrated multi-omic analyses in Biomphalaria-Schistosoma dialogue reveal the immunobiological significance of FREP-SmPoMuc interaction. , 2017, Developmental and comparative immunology.

[4]  R. Misra,et al.  Urinary haptoglobin, alpha‐1 anti‐chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis , 2017, Clinical and experimental immunology.

[5]  B. Nilsson,et al.  Cardiovascular disease in haemodialysis: role of the intravascular innate immune system , 2017, Nature Reviews Nephrology.

[6]  Q. Lu,et al.  Organ-specific biomarkers in lupus. , 2017, Autoimmunity reviews.

[7]  P. Aukrust,et al.  Complement activation by cholesterol crystals triggers a subsequent cytokine response , 2017, Molecular immunology.

[8]  A. Remaley,et al.  High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis. , 2017, Atherosclerosis.

[9]  R. Smalling,et al.  The Society of Thoracic Surgery Risk Score as a Predictor of 30-Day Mortality in Transcatheter vs Surgical Aortic Valve Replacement: A Single-Center Experience and its Implications for the Development of a TAVR Risk-Prediction Model. , 2017, The Journal of invasive cardiology.

[10]  D. Nelson,et al.  Gender balance in patients with systemic lupus erythematosus. , 2017, Autoimmunity reviews.

[11]  L. Christiansen,et al.  A Robust Statistical Model to Predict the Future Value of the Milk Production of Dairy Cows Using Herd Recording Data , 2017, Front. Vet. Sci..

[12]  A. Avan,et al.  Inorganic polyphosphate: a key modulator of inflammation , 2017, Journal of thrombosis and haemostasis : JTH.

[13]  A. Rawat,et al.  Complement in autoimmune diseases. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[14]  S. Valderramos,et al.  Validation of a Prediction Model for Vaginal Birth after Cesarean Delivery Reveals Unexpected Success in a Diverse American Population , 2017, American Journal of Perinatology Reports.

[15]  Xiao Han,et al.  Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells , 2017, International journal of molecular sciences.

[16]  P. Zhao,et al.  Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms , 2016, Oncotarget.

[17]  K. Kyriacou,et al.  Biomarkers of systemic lupus erythematosus identified using mass spectrometry‐based proteomics: a systematic review , 2016, Journal of cellular and molecular medicine.

[18]  D. Ye,et al.  The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study , 2017, Rheumatology International.

[19]  T. Motawi,et al.  MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus. , 2016, Chemico-biological interactions.

[20]  R. Deshmukh,et al.  Plant Aquaporins: Genome-Wide Identification, Transcriptomics, Proteomics, and Advanced Analytical Tools , 2016, Front. Plant Sci..

[21]  I. Baldwin,et al.  Transcriptome profiling reveals differential gene expression of detoxification enzymes in a hemimetabolous tobacco pest after feeding on jasmonate-silenced Nicotiana attenuata plants , 2016, BMC Genomics.

[22]  Synan F. AbuQamar,et al.  ‘Omics’ and Plant Responses to Botrytis cinerea , 2016, Frontiers in plant science.

[23]  V. V. Singh,et al.  RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities , 2016, PloS one.

[24]  B. Nilsson,et al.  Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross‐talk act as a linchpin in the events leading to thromboinflammation , 2016, Immunological reviews.

[25]  A. Blom,et al.  Complement in removal of the dead – balancing inflammation , 2016, Immunological reviews.

[26]  Liping Yang,et al.  Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry. , 2016, Biomedical chromatography : BMC.

[27]  S. Lemeer,et al.  Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy , 2016, Cellular and Molecular Life Sciences.

[28]  Ali Ebrahim,et al.  Multi-omic data integration enables discovery of hidden biological regularities , 2016, Nature Communications.

[29]  Dinesh Kumar,et al.  NMR based serum metabolomics reveals a distinctive signature in patients with Lupus Nephritis , 2016, Scientific Reports.

[30]  A. Heintz‐Buschart,et al.  Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes , 2016, Nature Microbiology.

[31]  M. Huber-Lang,et al.  Complement-coagulation crosstalk on cellular and artificial surfaces. , 2016, Immunobiology.

[32]  P. Böelle,et al.  Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus , 2016, PloS one.

[33]  J. Lu,et al.  Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis , 2016, Cell Death Discovery.

[34]  M. Kharboutli,et al.  Axl, Ferritin, Insulin‐Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus , 2016, Arthritis care & research.

[35]  R. Raghow.  An 'Omics' Perspective on Cardiomyopathies and Heart Failure. , 2016, Trends in molecular medicine.

[36]  Li Zhang,et al.  Therapeutic effect of double‐filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis , 2016, Journal of clinical apheresis.

[37]  Johan Trygg,et al.  Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren’s Syndrome and Systemic Sclerosis , 2016, PloS one.

[38]  Cuiping Liu,et al.  Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus , 2016, Archives of Dermatological Research.

[39]  M. Iadarola,et al.  Transcriptomic Segregation of Human Autoantigens Useful for the Diagnosis of Autoimmune Diseases , 2016, Molecular Diagnosis & Therapy.

[40]  Yanxia Sun,et al.  RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs. , 2016, Pathology, research and practice.

[41]  Liping Yang,et al.  Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS , 2016, Modern rheumatology.

[42]  U. Landmesser,et al.  Tissue factor as a link between inflammation and coagulation. , 2016, Trends in cardiovascular medicine.

[43]  J. Muñóz-Valle,et al.  Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus , 2016, Lupus.

[44]  Virginia Pascual,et al.  Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients , 2016, Cell.

[45]  F. Fregni,et al.  Salivary proteomics: A new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus. , 2016, Medical hypotheses.

[46]  Hiroyuki Kubota,et al.  Trans-Omics: How To Reconstruct Biochemical Networks Across Multiple 'Omic' Layers. , 2016, Trends in biotechnology.

[47]  B. Nilsson,et al.  The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation , 2016, Journal of thrombosis and haemostasis : JTH.

[48]  M. Rudnicki,et al.  Renal microRNA‐ and RNA‐profiles in progressive chronic kidney disease , 2016, European journal of clinical investigation.

[49]  Y. Shoenfeld,et al.  Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. , 2016, Clinical immunology.

[50]  M. Connelly,et al.  GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus , 2016, Lupus.

[51]  J. Choe,et al.  Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus , 2016, Inflammation Research.

[52]  L. Isaac,et al.  Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway , 2016, Front. Immunol..

[53]  L. Fang,et al.  PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus , 2016, Arthritis Research & Therapy.

[54]  Olga A. Kleyst,et al.  Virtual-Experimental 2DE Approach in Chromosome-Centric Human Proteome Project. , 2016, Journal of proteome research.

[55]  A. Blom,et al.  Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes , 2016, Cell Death and Differentiation.

[56]  C. Molta,et al.  Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab , 2015, Lupus.

[57]  E. Antiga,et al.  Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus. , 2016, Clinical and experimental rheumatology.

[58]  C. Mohan,et al.  Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? , 2015, BMJ : British Medical Journal.

[59]  A. Atta,et al.  High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction , 2015, Journal of immunology research.

[60]  G. Desir,et al.  Serum Renalase Levels Correlate with Disease Activity in Lupus Nephritis , 2015, PloS one.

[61]  D. Gladman,et al.  SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement , 2015, The Journal of Rheumatology.

[62]  M. Terreri,et al.  Lipid profile among girls with systemic lupus erythematosus , 2015, Rheumatology International.

[63]  Ping Liu,et al.  Pregnancy-induced metabolic phenotype variations in maternal plasma. , 2014, Journal of proteome research.

[64]  G. Heinze,et al.  d‐Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model , 2014, Journal of the American Heart Association.

[65]  Zhuoli Zhang,et al.  Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus. , 2014, Clinical and experimental rheumatology.

[66]  Hui Li,et al.  Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein , 2013, Experimental and therapeutic medicine.

[67]  M. Adams,et al.  Thrombosis in Systemic Lupus Erythematosus: Role of Impaired Fibrinolysis , 2013, Seminars in Thrombosis & Hemostasis.

[68]  C. Pieper,et al.  The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease , 2013, Lupus.

[69]  K. Hamulýak,et al.  The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[70]  F. Dove.  Drug-induced lupus , 1982 .